WATCH: Top experts answer questions about vaccine safety, effectiveness and availability

WATCH: Top experts answer questions about vaccine safety, effectiveness and availability

Two top Advocate Aurora Health doctors on Wednesday addressed viewer questions about vaccines, COVID-19, masks and when life might get back to normal during a discussion on Facebook Live. Executive Medical Director of Infectious Disease and Prevention Dr. Robert Citronberg

Read More WATCH: Top experts answer questions about vaccine safety, effectiveness and availability

Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study

Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults Elisabetta Patorno, Ajinkya Pawar, Lily G. Bessette, Dae H. Kim, Chintan Dave, Robert J. Glynn, Medha N. Munshi, Sebastian Schneeweiss, Deborah J.

Read More Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort

Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort Neda Rasouli, Naji Younes, Kristina M. Utzschneider, Silvio E. Inzucchi, Ashok Balasubramanyam, Andrea L. Cherrington, Faramarz Ismail-Beigi,

Read More Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort

Coronavirus: London, Ont., team creates tool to measure effectiveness, privacy of COVID-19 apps

Coronavirus: London, Ont., team creates tool to measure effectiveness, privacy of COVID-19 apps

A duo out of Western University in London, Ont., has created a new tool that they say will help provincial and national policymakers make decisions on which of the “near-endless stream” of contact-tracing apps to utilize.Public health officials use

Read More Coronavirus: London, Ont., team creates tool to measure effectiveness, privacy of COVID-19 apps

Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases

Response to Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948–955

Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases Yan Xie, Benjamin Bowe, Andrew K. Gibson, Janet B. McGill, Geetha Maddukuri, Yan Yan,

Read More Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases

Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events

Response to Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948–955

AbstractOBJECTIVE To examine the comparative effectiveness of the sodium–glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin and other non-SGLT2i antihyperglycemics on the risk of major adverse kidney events (MAKE) of estimated glomerular filtration rate (eGFR) decline >50%, end-stage kidney disease, or all-cause

Read More Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events

Dubai Diabetes Centre exploring effectiveness of virtual health follow-ups using remote devices

home-monitoring devices, mobile technology

A new study exploring the effectiveness of virtual health follow-ups using home-monitoring devices and mobile technology is currently being conducted by the Dubai Diabetes Centre (DDC) with the support of the Dubai Health Authority (DHA) in the United Arab Emirates.

Read More Dubai Diabetes Centre exploring effectiveness of virtual health follow-ups using remote devices

5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’

5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’

President Donald Trump makes no secret he would like a COVID-19 vaccine to be available before the election. But it’s doubtful that will happen and, even after a vaccine wins FDA approval, there would be a long wait before it’s

Read More 5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’

Internet CBT for pediatric OCD maintains, or even increases, effectiveness over 12 months

Internet CBT for pediatric OCD maintains, or even increases, effectiveness over 12 months

New data suggest that an Internet-delivered cognitive behavioral therapy (ICBT) intervention not only remained effective after 12 months among adolescents with obsessive-compulsive disorder, but seemed to have an even greater impact on their symptoms with time. Published last week in

Read More Internet CBT for pediatric OCD maintains, or even increases, effectiveness over 12 months

Measuring the Effectiveness of Cost-of-Care Conversations – The Health Care Blog

Measuring the Effectiveness of Cost-of-Care Conversations – The Health Care Blog

By NELLY GANESAN, JOSH SEIDMAN, MORENIKE AYOVAUGHAN, and RINA BARDIN With support from the Robert Wood Johnson Foundation, Avalere assesses opportunities to normalize cost-of-care conversations through measurement. Cost continues to pose a barrier to accessing healthcare for millions of Americans.

Read More Measuring the Effectiveness of Cost-of-Care Conversations – The Health Care Blog